Recombinant CD44 , CD44V (Bivatuzumab Biosimilar) antibody

Catalog No. ABIN7597560

This Humanized Chimeric antibody specifically detects CD44 , CD44V (Bivatuzumab Biosimilar) in not_set. It exhibits reactivity toward Human.

Quick Overview for Recombinant CD44 , CD44V (Bivatuzumab Biosimilar) antibody (ABIN7597560)

Target: CD44 , CD44V (Bivatuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD44 , CD44V (Bivatuzumab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-CD44 , CD44V (Bivatuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Bivatuzumab Biosimilar Antibody

Specificity: Hyaluronate receptor, MDU2, HUTCH-I, MDU3, Phagocytic glycoprotein I, CDw44, Epican, Phagocytic glycoprotein 1, ECMR-III, CD44, Hermes antigen, PGP-1, PGP-I, GP90 lymphocyte homing/adhesion receptor, LHR, CD44 antigen, MIC4, Extracellular matrix receptor III, Heparan sulfate proteoglycan

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD44 , CD44V (Bivatuzumab Biosimilar)

Target: CD44 , CD44V (Bivatuzumab Biosimilar)

Alternative Name: Bivatuzumab Biosimilar

Target Type: Biosimilar

Background: Hyaluronate receptor, MDU2, HUTCH-I, MDU3, Phagocytic glycoprotein I, CDw44, Epican, Phagocytic glycoprotein 1, ECMR-III, CD44, Hermes antigen, PGP-1, PGP-I, GP90 lymphocyte homing/adhesion receptor, LHR, CD44 antigen, MIC4, Extracellular matrix receptor III, Heparan sulfate proteoglycan

UniProt: P16070

CAS-No: 214559-60-1